Oncology companies develop therapies, diagnostics and technologies that support the detection, monitoring and treatment of cancer. The sector is one of the largest and most active areas of biotechnology and pharmaceutical innovation.
This category includes companies working on:
Browse 256 UK oncology companies below.
Preclinical CRO for receptor pharmacology and occupancy studies
Gifford Bioscience is a contract research organisation providing receptor pharmacology and occupancy services for preclinical and discovery stage drug development. The company…
AI platform predicting patient response to cancer immunotherapy
Curenetics is a medical technology company developing AI-powered tools to predict cancer patient responses to immunotherapy before treatment begins. Its platform integrates…
Off-the-shelf Natural Killer cell therapies for solid and blood cancers
NK:IO develops cancer immunotherapies based on human Natural Killer cells, harnessing the body's innate immune system as an alternative to T-cell-based approaches. The company's…
Oncolytic adenovirus therapeutics for solid tumour cancer treatment
PsiVac is a UK-based biotechnology company developing oncolytic virus therapeutics for the treatment of cancer. Its patented technology uses genetically modified adenoviruses…
Small molecule MMR inhibitors to enhance tumour immunogenicity
NeoPhore is a UK immuno-oncology company developing first-in-class small molecule inhibitors of the DNA mismatch repair pathway. By transiently blocking MMR, the company's…
European specialty pharma focused on gastroenterology and hepatology
Norgine is a European specialty pharmaceutical company developing, manufacturing, and commercialising medicines across gastroenterology, hepatology, and cancer supportive care.…
Liquid biopsy NGS kits and genomic diagnostic services
Nonacus is a developer of next-generation sequencing reagents and library preparation kits for liquid biopsy and tissue-based genomic analysis. Its target enrichment and cell-free…
Global licensing and commercialisation of established branded pharmaceutical medicines
Pharmanovia is a specialty pharmaceutical company that acquires, licenses and commercialises established branded medicines, extending their lifecycle for patients worldwide. The…
AI-powered bioinformatics platform for precision oncology and drug discovery
Rayca Precision develops AI and bioinformatics platforms for precision oncology and drug discovery, using transcriptomic data and deep learning to predict drug responses and…
Clinical-stage biopharma improving nucleoside analogue chemotherapy efficacy
NuCana is a clinical-stage biopharmaceutical company developing a pipeline of cancer medicines using proprietary phosphoramidate prodrug chemistry. Its approach transforms…
Carbohydrate binding molecules targeting the tumour glycome in cancer
Omideon is a Scottish preclinical biotechnology company applying multivalent carbohydrate binding molecule (mCBM) technology to oncology. Spun out from Pneumagen Limited by…
Infrared spectroscopy blood test for early multi-cancer detection
Dxcover is a clinical-stage biotechnology company developing a blood-based multi-cancer early detection test. Its platform applies infrared spectroscopy to a dried blood spot to…